Investigational Site Number 528004

Eindhoven 5631 BM

0 studies enrolling now · 2 studies all time

What they study most

Squamous Cell Lung Cancer, Type 2 Diabetes Mellitus

Studies at this site

• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin — Completed
• Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) — Completed